Jyong Biotech Ltd. (NASDAQ:MENS - Get Free Report) gapped up prior to trading on Tuesday . The stock had previously closed at $54.81, but opened at $56.97. Jyong Biotech shares last traded at $57.00, with a volume of 1,936 shares.
Wall Street Analysts Forecast Growth
Separately, Wall Street Zen upgraded Jyong Biotech to a "hold" rating in a report on Monday, June 30th.
Check Out Our Latest Research Report on MENS
Jyong Biotech Price Performance
The company's fifty day moving average is $28.40.
Jyong Biotech Company Profile
(
Get Free Report)
OUR MISSION We endeavor to develop and supply first-class innovative drugs to meet our customers' health needs. We seek to be a valuable business organization that is held in high esteem by the public. We are a science-driven biotechnology company based in Taiwan and are committed to developing and commercializing innovative and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU, and Asia.
See Also
Before you consider Jyong Biotech, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Jyong Biotech wasn't on the list.
While Jyong Biotech currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
